StockData
Lyell Immunopharma, Inc. logo

Lyell Immunopharma, Inc. (LYEL) stock

LYELNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/30
$13.89+0.22 (+1.61%)

Close on Nov 18, 2026Market cap $340.38MP/E –Yield –

Lyell Immunopharma pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

No pe ratio figures for Lyell Immunopharma

Lyell Immunopharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Lyell Immunopharma figures

See a number that looks wrong?